The announcement by Atara Biotherapeutics Inc. that it was raising $36 million through a registered direct offering sat well with investors. Thousand Oaks-based drug company made the announcement after the market closed on Sept. 3. The following day the stock rose nearly 33% to end the day at $9.05. The increase in share price continued a trend of sorts in play for Atara since its 1:25 stock split on June 20. On that day the share price closed a…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.